Oppenheimer Asset Management Inc. lifted its position in athenahealth, Inc. (NASDAQ:ATHN) by 2.4% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 31,974 shares of the health services provider’s stock after buying an additional 737 shares during the period. Oppenheimer Asset Management Inc. owned about 0.08% of athenahealth worth $3,977,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. FMR LLC increased its position in shares of athenahealth by 0.8% in the 2nd quarter. FMR LLC now owns 5,975,119 shares of the health services provider’s stock valued at $839,803,000 after buying an additional 47,341 shares in the last quarter. Janus Henderson Group PLC bought a new stake in shares of athenahealth in the 2nd quarter valued at $713,856,000. Vanguard Group Inc. increased its position in shares of athenahealth by 1.8% in the 2nd quarter. Vanguard Group Inc. now owns 3,100,643 shares of the health services provider’s stock valued at $435,795,000 after buying an additional 53,361 shares in the last quarter. Capital Research Global Investors increased its position in shares of athenahealth by 15.5% in the 2nd quarter. Capital Research Global Investors now owns 2,041,714 shares of the health services provider’s stock valued at $286,963,000 after buying an additional 273,660 shares in the last quarter. Finally, BlackRock Inc. increased its position in shares of athenahealth by 2.0% in the 2nd quarter. BlackRock Inc. now owns 1,631,993 shares of the health services provider’s stock valued at $229,377,000 after buying an additional 32,146 shares in the last quarter.

In other news, Director Brandon H. Hull sold 800 shares of the stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $132.97, for a total transaction of $106,376.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Jonathan D. Porter sold 300 shares of the stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $130.38, for a total transaction of $39,114.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 9,283 shares of company stock valued at $1,175,908. Company insiders own 3.20% of the company’s stock.

A number of analysts recently commented on ATHN shares. Robert W. Baird lowered their price objective on shares of athenahealth from $170.00 to $155.00 and set an “outperform” rating for the company in a research report on Sunday, October 22nd. TheStreet cut athenahealth from a “b-” rating to a “c+” rating in a report on Wednesday, October 11th. First Analysis upgraded athenahealth from an “underweight” rating to an “equal weight” rating and increased their target price for the stock from $125.00 to $127.00 in a report on Monday, October 23rd. Leerink Swann set a $155.00 target price on athenahealth and gave the stock a “hold” rating in a report on Thursday, October 19th. Finally, Jefferies Group lowered their target price on athenahealth from $135.00 to $120.00 and set a “hold” rating for the company in a report on Friday, September 15th. Two equities research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and eleven have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $143.29.

athenahealth, Inc. (ATHN) opened at $131.86 on Friday. athenahealth, Inc. has a one year low of $92.38 and a one year high of $158.66. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.67 and a current ratio of 1.67. The company has a market cap of $5,276.77, a PE ratio of 111.75, a PEG ratio of 4.95 and a beta of 1.57.

athenahealth (NASDAQ:ATHN) last posted its quarterly earnings data on Thursday, October 19th. The health services provider reported $0.56 EPS for the quarter, topping the Zacks’ consensus estimate of $0.50 by $0.06. athenahealth had a net margin of 2.65% and a return on equity of 6.78%. The company had revenue of $304.60 million during the quarter, compared to the consensus estimate of $310.52 million. During the same period in the prior year, the business posted $0.60 EPS. The company’s quarterly revenue was up 10.1% on a year-over-year basis. research analysts anticipate that athenahealth, Inc. will post 1.2 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This report was first posted by Watch List News and is owned by of Watch List News. If you are accessing this report on another website, it was stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this report can be accessed at https://www.watchlistnews.com/athenahealth-inc-athn-position-increased-by-oppenheimer-asset-management-inc/1755204.html.

athenahealth Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.